In Focus

Patients fighting life-threatening illnesses who have run out of conventional options will get a chance to try some of the most cutting-edge treatments available, through a national effort that just received nearly $4.8 million in funding from the federal government.

Based at the University of Michigan, in partnership with Duke University, the University of Texas Southwestern Medical Center and the University of Rochester, the effort will build a national framework to help more patients gain access to experimental drugs, devices and biologics. It is funded by the National Center for Advancing Translational Sciences, part of the National Institutes of Health.

CBSSM News & Events

Andrew Shuman Panelist at AAMC Learn Serve Lead 2018
Andrew Shuman recently served on the panel, “Creating Zero Tolerance: Institutional Policies to Confront Biased Patients,” at the Association of American Medical Colleges (AAMC) Learn Serve Lead 20
Read more.
Plastic Surgeons on Snapchat: Stahl and Vercler - Episode 10 11/09/2018
Check out the latest episode of "No Easy Answers in Bioethics" hosted by MSU's Center for Ethics and Humanities in the Life Sciences.
Read more.
CBSSM Seminar: Amy Pienta, PhD 11/27/2018
Amy Pienta, PhD Research Scientist and Director, Business and Collection Development ICPSR, University of Michigan Title: Sharing, Finding, and Using Health Data at ICPSR
Read more.